Delayed ischemic preconditioning is mediated by opening of ATP-sensitive potassium channels in the rabbit heart

被引:95
作者
Bernardo, NL
D'Angelo, M
Okubo, S
Joy, A
Kukreja, RC
机构
[1] Virginia Commonwealth Univ, Med Coll Virginia, Dept Med, Div Cardiol, Richmond, VA 23298 USA
[2] Kanazawa Med Univ, Dept Cardiol, Kahoku, Kahoku, Ishikawa 9200293, Japan
来源
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY | 1999年 / 276卷 / 04期
关键词
action potential; myocardial infarction; ischemia-reperfusion injury; mitochondrial and sarcolemmal adenosine 5 '-triphosphate-sensitive potassium channel; protein kinase C;
D O I
10.1152/ajpheart.1999.276.4.H1323
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Cardioprotection from preconditioning reappears 24 h after the initial stimulus. This phenomenon is called the second window of protection (SWOP). We hypothesized that opening of the ATP-sensitive potassium (K-ATP) channel mediates the protective effect of SWOP. Rabbits were preconditioned (PC) with four cycles of 5-min regional ischemia each followed by 10 min of reperfusion. Twenty-four hours later, the animals were subjected to sustained ischemia for 30 min followed by 180 min of reperfusion (I/R). Glibenclamide (Glib, 0.3 mg/kg ip) or 5-hydroxydecanoate (5-HD, 5 mg/kg iv) was used to block the KATP channel function. Infarct size was reduced from 41.2 +/- 2.6% in sham-operated rabbits to 11.6 +/- 1.0% in PC rabbits, a 71% reduction (n = 11, P < 0.01). Treatment with Glib or 5-HD before I/R increased the infarct size to 43.4 +/- 2.6 and 37.8 +/- 1.9%, respectively (P < 0.01 vs. PC group, n = 12/group). Sham animals treated with either Glib or 5-HD had an infarct size of 39.0 +/- 3.4 and 37.8 +/- 1.5%, respectively, which was not different from control(40.0 +/- 3.8%) or sham (41.2 +/- 2.6%) I/R hearts. Monophasic action potential duration (APD) at 50% repolarization significantly shortened by 28.7, 26.6, and 23.3% in sham animals during 10, 20, and 30 min of ischemia. However, no further augmentation in the shortening of APD was observed in PC hearts. Glib and 5-HD significantly suppressed ischemia-induced epicardial APD shortening, suggesting that 5-HD may not be a selective blocker of the mitochondrial KATP channel in vivo. Five conclude that SWOP is mediated by a KATP channel-sensitive mechanism that may have occurred because of the opening of the sarcolemmal KATP channel in vivo.
引用
收藏
页码:H1323 / H1330
页数:8
相关论文
共 56 条
  • [1] Baines CP, 1998, CIRCULATION, V98, P343
  • [2] ADENOSINE RECEPTOR INVOLVEMENT IN A DELAYED PHASE OF MYOCARDIAL PROTECTION 24 HOURS AFTER ISCHEMIC PRECONDITIONING
    BAXTER, GF
    MARBER, MS
    PATEL, VC
    YELLON, DM
    [J]. CIRCULATION, 1994, 90 (06) : 2993 - 3000
  • [3] INVOLVEMENT OF PROTEIN-KINASE-C IN THE DELAYED CYTOPROTECTION FOLLOWING SUBLETHAL ISCHEMIA IN RABBIT MYOCARDIUM
    BAXTER, GF
    GOMA, FM
    YELLON, DM
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1995, 115 (02) : 222 - 224
  • [4] Attenuation of myocardial ischaemic injury 24 h after diacylglycerol treatment in vivo
    Baxter, GF
    Mocanu, MM
    Yellon, DM
    [J]. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1997, 29 (07) : 1967 - 1975
  • [5] EFFECTS OF GLYBURIDE ON ISCHEMIA-INDUCED CHANGES IN EXTRACELLULAR POTASSIUM AND LOCAL MYOCARDIAL ACTIVATION - A POTENTIAL NEW APPROACH TO THE MANAGEMENT OF ISCHEMIA-INDUCED MALIGNANT VENTRICULAR ARRHYTHMIAS
    BEKHEIT, SS
    RESTIVO, M
    BOUTJDIR, M
    HENKIN, R
    GOOYANDEH, K
    ASSADI, M
    KHATIB, S
    GOUGH, WB
    ELSHERIF, N
    [J]. AMERICAN HEART JOURNAL, 1990, 119 (05) : 1025 - 1033
  • [6] BERNARDO NL, 1997, CIRCULATION S1, V96, P553
  • [7] BERNARDO NL, 1997, CIRCULATION S1, V96, P257
  • [8] Cameron John S., 1996, FASEB Journal, V10, pA65
  • [9] ROLE OF ATP-SENSITIVE POTASSIUM CHANNELS IN LONG-TERM ADAPTATION TO METABOLIC STRESS
    CAMERON, JS
    BAGHDADY, R
    [J]. CARDIOVASCULAR RESEARCH, 1994, 28 (06) : 788 - 796
  • [10] PROFIBRILLATORY ACTIONS OF PINACIDIL IN A CONSCIOUS CANINE MODEL OF SUDDEN CORONARY DEATH
    CHI, L
    UPRICHARD, ACG
    LUCCHESI, BR
    [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1990, 15 (03) : 452 - 464